451-03-016 / 451-03-016 ISMRM Abstract

Improving Risk Stratification of Myocarditis with Quantitative CMR: External Validation of the 2025 ESC Guideline

Primary: Cardiovascular - Inflammation, Infiltration

Secondary: Cardiovascular - Myocardium

451-03-016 · Cardiac Structure, Function, and Tissue Characterization · Tuesday, 12 May, 4:00 PM–5:36 PM · Power Pitch Theatre 1

Keywords: Myocarditis T1 Mapping Risk Stratification Guideline Cardiovascular magnetic resonance imaging

Accepted

Yining Wang ¹, Jing An², Kelvin Chow³, Minjie Lu⁴

¹Department of Radiology, National Center for Cardiovascular Diseases and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

²Magnetic resonance, Siemens Shenzhen Magnetic Resonance Ltd., Shenzhen, China

³Cardiovascular MR R&D, Siemens Healthcare Ltd., Calgary, Canada

⁴Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Presenting Author: Yining Wang

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. doi: 10.1093/ehjqcco/qcae069. [doi]

2. doi: 10.1001/jama.2023.3371. [doi]

3. doi: 10.1136/heartjnl-2021-319027. [doi]

4. doi: 10.1093/eurheartj/ehaf192. [doi]

5. doi: 10.1016/j.jcmg.2021.11.017. [doi]

6. doi: 10.1016/j.jacc.2018.09.072. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/451-03-016